Composition and properties of silver-containing calcium carbonate-calcium phosphate bone cement

Journal of Materials Science: Materials in Medicine

Volumn 24, Issue 12, 2013, Pages 2665-2675

  Jacquart, Sylvaine ^a   Siadous, Robin ^b,c   Henocq Pigasse, Christel ^d   Bareille, Reine ^b,c   Roques, Christine ^d   Rey, Christian ^a   Combes, Christèle ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b University Bordeaux Segalen   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-BACTERIAL ACTIVITY; ANTIBACTERIAL PROPERTIES; BIOLOGICAL PROPERTIES; FTIR SPECTROSCOPY; HUMAN BONE MARROW STROMAL CELLS (HBMSC); IMPLANT-ASSOCIATED INFECTION; SILVER NITRATE SOLUTIONS; SILVER PHOSPHATE;

CALCIUM CARBONATE; FOURIER TRANSFORM INFRARED SPECTROSCOPY; PHOSPHATE MINERALS; SILVER ALLOYS;

BONE CEMENT;

BONE CEMENT; CALCIUM CARBONATE; CALCIUM PHOSPHATE;

ANTIBACTERIAL ACTIVITY; ARTICLE; CELL VIABILITY; CHEMICAL REACTION; COLONY FORMING UNIT; IN VITRO STUDY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SOLID; SOLUBILITY; X RAY DIFFRACTION;

STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; APATITES; BIOFILMS; BONE CEMENTS; BONE MARROW CELLS; BONE SUBSTITUTES; CALCIUM CARBONATE; CALCIUM PHOSPHATES; HUMANS; MATERIALS TESTING; MICROBIAL SENSITIVITY TESTS; POWDERS; PROSTHESES AND IMPLANTS; SILVER; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STROMAL CELLS;

EID: 84890312461     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-013-5014-2     Document Type: Article

References (40)

1. Brown WE, Chow LC. A new calcium phosphate setting cement. J Dent Res. 1983;62:672.
2. Bohner M. Design of ceramic-based cements and putties for bone graft substitution. Eur Cells Mater. 2010;20:1-12.
3. Sugawara A, Asaoka K, Ding S-J. Calcium phosphate-based cements: clinical needs and recent progress. J Mater Chem B. 2013;1:1081-9.
4. Combes C, Bareille R, Rey C. Calcium carbonate-calcium phosphate mixed cement compositions for bone reconstruction. J Biomed Mater Res Part A. 2006;79:318-28.
5. Ginebra M-P, Canal C, Espanol M, Pastorino D, Montufar EB. Calcium phosphate cements as drug delivery materials. Adv Drug Deliv Rev. 2012;64:1090-110.
6. Joosten U, Joist A, Frebel T, Brandt B, Diederichs S, Von Eiff C. Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamicin in the treatment of chronic osteomyelitis: studies in vitro and in vivo. Biomaterials. 2004;25:4287-95.
7. Liu WC, Wong CT, Fong MK, Cheung WS, Kao RYT, Luk KDK, et al. Gentamicin-loaded strontium-containing hydroxyapatite bioactive bone cement - an efficient bioactive antibiotic drug delivery system. J Biomed Mater Res B Appl Biomater. 2010;95:397-406.
8. Hesaraki S, Nemati R. Cephalexin-loaded injectable macroporous calcium phosphate bone cement. J Biomed Mater Res B Appl Biomater. 2009;89:342-52.
9. Sasaki T, Ishibashi Y, Katano H, Nagumo A, Toh S. In vitro elution of vancomycin from calcium phosphate cement. J Arthroplasty. 2005;20:1055-9.
10. Jiang P-J, Patel S, Gbureck U, Caley R, Grover LM. Comparing the efficacy of three bioceramic matrices for the release of vancomycin hydrochloride. J Biomed Mater Res B Appl Biomater. 2010;93:51-8.
11. Serraj S, Michaïlesco P, Margerit J, Bernard B, Boudeville P. Study of a hydraulic calcium phosphate cement for dental applications. J Mater Sci Mater Med. 2002;13:125-31.
12. Michaïlesco P, Kouassi M, El Briak H, Armynot A, Boudeville P. Antimicrobial activity and tightness of a DCPD-CaO-based hydraulic calcium phosphate cement for root canal filling. J Biomed Mater Res B Appl Biomater. 2005;74:760-7.
13. Gbureck U, Knappe O, Grover LM, Barralet JE. Antimicrobial potency of alkali ion substituted calcium phosphate cements. Biomaterials. 2005;26:6880-6.
14. Lansdown ABG. A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices. Adv Pharmacol Sci. 2010;2010:1-16.
15. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res. 2000;52:662-8.
16. Berbari EF, Hanssen AD, Duffy MC, Steckelberg JM, Ilstrup DM, Harmsen WS, et al. Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis. 1998;27:1247-54.
17. Lansdown ABG. Silver in healthcare: its antimicrobial efficacy and safety in use. Cambridge: Royal Society of Chemistry; 2010.
18. 2+) in hydroxyapatite. J Mater Sci Mater Med. 1998;9:129-34.
19. 2 (0.0 ≤ x ≤ 0.5) hydroxyapatites. Mater Sci Eng C. 2011;31:1320-9.
20. Chen W, Liu Y, Courtney HS, Bettenga M, Agrawal CM, Bumgardner JD, et al. In vitro anti-bacterial and biological properties of magnetron co-sputtered silver-containing hydroxyapatite coating. Biomaterials. 2006;27:5512-7.
21. Ando Y, Miyamoto H, Noda I, Sakurai N, Akiyama T, Yonekura Y, et al. Calcium phosphate coating containing silver shows high antibacterial activity and low cytotoxicity and inhibits bacterial adhesion. Mater Sci Eng C. 2010;30:175-80.
22. Ghafari Nazari A, Tahari A, Moztarzadeh F, Mozafari M, Bahrololoom ME. Ion exchange behaviour of silver-doped apatite micro- and nanoparticles as antibacterial biomaterial. Micro Nano Lett. 2011;6:713-7.
23. + ions into micro-porous hydroxyapatite coatings. Mater Lett. 1995;24:7-12.
24. Lee JS, Murphy WL. Functionalizing calcium phosphate biomaterials with antibacterial silver particles. Adv Mater. 2013;25:1173-9.
25. Venkateswarlu K, Rameshbabu N, Chandra Bose A, Muthupandi V, Subramanian S, MubarakAli D, et al. Fabrication of corrosion resistant, bioactive and antibacterial silver substituted hydroxyapatite/titania composite coating on Cp Ti. Ceram Int. 2012;38:731-40.
26. Lim, PN, Teo EY, Ho B, Tay BY, Thian ES. Effect of silver content on the antibacterial and bioactive properties of silver-substituted hydroxyapatite. J Biomed Mater Res Part A. 2013;101:2456-64.
27. Spadaro J, Webster D, Becker R. Silver polymethyl methacrylate antibacterial bone cement. Clin Orthop Relat Res. 1979;143:266-70.
28. Alt V, Bechert T, Steinrücke P, Wagener M, Seidel P, Dingeldein E, et al. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials. 2004;25:4383-91.
29. Ewald A, Hösel D, Patel S, Grover LM, Barralet JE, Gbureck U. Silver-doped calcium phosphate cements with antimicrobial activity. Acta Biomater. 2011;7:4064-70.
30. Evaluation biologique des dispositifs médicaux. Partie 5: Essais concernant la cytotoxicité: Méthodes in vitro. AFNOR NF EN 30993-5-ISO 10993-5 1994.
31. Vilamitjana-Amédée J, Bareille R, Rouais F, Caplan AI, Harmand MF. Human bone marrow stromal cells express an osteoblastic phenotype in culture. In Vitro Cell Dev Biol Anim. 1993;29:699-707.
32. Parish CR, Müllbacher A. Automated colorimetric assay for T cell cytotoxicity. J Immunol Methods. 1983;58:225-37.
33. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
34. Khalilzadeh P, Lajoie B, El Hage S, Furiga A, Baziard G, Berge M, et al. Growth inhibition of adherent Pseudomonas aeruginosa by an N-butanoyl-l- homoserine lactone analog. Can J Microbiol. 2010;56:317-25.
35. Combes C, Bareille R, Rey C. Calcium carbonate-calcium phosphate mixed cement compositions for bone reconstruction. J Biomed Mater Res Part A. 2006;79A:318-28.
36. Eichert D, Drouet C, Sfihi H, Rey C, Combes C. Nanocrystalline apatite-based biomaterials: synthesis, processing and characterization. In: Kendall JB, editor. Biomaterials research advances, New York: Nova Science Publishers; 2007. pp. 93-143.
37. Vandecandelaere N. Ph.D. Thesis. Élaboration et caractérisation de biomatériaux osseux innovants à base d'apatites phospho-calciques dopées. Université de Toulouse, Institut National Polytechnique de Toulouse; 2012.
38. Palmer M, Costerton W, Sewecke J, Altman D. Molecular techniques to detect biofilm bacteria in long bone nonunion: a case report. Clin Orthop Relat Res. 2011;469:3037-42.
39. Ciampolini J, Harding K. Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often? Postgrad Med J. 2000;76:479-83.
40. Carek PJ, Dickerson LM, Sack JL. Diagnosis and management of osteomyelitis. Am Fam Physician. 2001;63:2413-21.